+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Non-Therapeutic Biomolecules Global Market Report 2024

  • PDF Icon

    Report

  • 200 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5790689

Quick Summary:

In today's rapidly evolving biopharma industry, a nuanced understanding of market dynamics is indispensable for decision making. Our new report on the global non-therapeutic biomolecules market offers precisely that. A sequel to a series aimed at analyzing this emerging market, the report delivers insightful data including regional shares, market trends, and innovative market opportunities that are crucial for thriving in this space. The report provides an exhaustive analysis of current and future market scenarios.

Notably, the non-therapeutic biomolecules market is witnessing an influx of product innovations making the bio-pharma marketplace even more competitive. Major companies are focusing their efforts on R&D and product innovations, resulting in the birth of new products and collaborations that will shape the industry's future.

This comprehensive market research report can facilitate your understanding of the increasingly complex non-therapeutic biomolecules market, highlighting key industry trends and strategies for weathering market fluctuations. Use this research to inform your strategic planning and to maintain a competitive edge in an increasingly dynamic market.

The primary classifications of non-therapeutic biomolecules in traditional pharmaceuticals encompass enzymes, recombinant proteins, plasmids, peptides, oligonucleotides, and monoclonal antibodies. Enzymes, for instance, are specialized globular proteins that accelerate biological reactions by lowering the activation energy needed for these processes. These biomolecules find application across diverse sectors including research, pharmaceuticals, and in vitro diagnostics (IVD), contributing significantly to various end-users' operational needs.

This report provides non-therapeutic biomolecules market statistics, including the non-therapeutic biomolecules industry’s global market size, regional shares, competitors with a non-therapeutic biomolecules market share, detailed non-therapeutic biomolecules market segments, market trends, and opportunities, and any further data you may need to thrive in the non-therapeutic biomolecules industry. This non-therapeutic biomolecules market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global non-therapeutic biomolecules market has grown rapidly in recent years. It will grow from $27.91 billion in 2023 to $31.11 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth observed in the historical period can be attributed to several factors, including amplified investments in research and development (R&D), expanding applications in research and diagnostics, an increase in awareness and subsequent adoption, strategic collaborations and partnerships within the industry, and regulatory support fostering advancement in the field.

The global non-therapeutic biomolecules market is expected to see rapid growth in the next few years. It will grow to $47.21 billion in 2028 at a compound annual growth rate (CAGR) of 11.0%. The anticipated growth in the upcoming period can be credited to emerging market opportunities, advancements in data analytics and integration, a heightened emphasis on precision medicine, escalating investments in personalized healthcare, and the broadening of application areas within the industry. Key trends expected in this period encompass significant technological advancements, an increase in strategic collaborations, a rising presence in agricultural applications, an expanding role in industrial processes, and an increasing focus on customization and personalization within the field.

The growing volume of research and laboratory assessments is poised to ignite expansion within the non-therapeutic biomolecules market. Laboratory testing involves the analysis of bodily samples like blood or urine to diagnose and monitor diseases, while research involves generating new knowledge or innovatively applying existing concepts. Non-therapeutic biomolecules, integral to laboratory testing, aid in gauging biomarker molecule presence or concentration, amplifying test sensitivity and accuracy. For instance, the American Association for Clinical Chemistry reports that over 200,000 CLIA-certified labs in the US conduct nearly 13 billion tests yearly, with laboratory services constituting 2.3% of healthcare expenses and two percent of Medicare expenditures, thereby fueling the growth of the non-therapeutic biomolecules market.

The surge in healthcare expenditure is anticipated to drive growth in the non-therapeutic biomolecules market. Increased healthcare spending typically translates to amplified funding for medical research and development. Non-therapeutic biomolecules play a crucial role in diagnostic tools and tests. Heightened healthcare investment often signals a stronger emphasis on disease prevention, early detection, and personalized medicine. This heightened focus on diagnostics stands to contribute significantly to the expansion of the non-therapeutic biomolecules market. As evidenced in the Economic Survey of 2022 by the Ministry of Finance, Government of India, the country's healthcare expenditure surged to 2.1% of GDP in 2021-22 from 1.8% in 2020-21, indicating a driving force behind the market's growth during the forecast period.

Product innovation emerges as a prominent trend in the non-therapeutic biomolecules market. Major industry players concentrate on research and development to introduce innovative products, fortifying their market position. An example is BASF SE collaborating with Caregen in January 2022 to unveil the Peptovitae series, employing liposome-encapsulation technology in dermo-cosmetics. This series addresses diverse skin concerns like aging signs, skin brightness enhancement, dryness relief, and moisturization, showcasing the potential of innovative biomolecule applications.

Companies in the non-therapeutic biomolecules sector prioritize developing advanced cell separation technologies for competitive advantage. Notably, Akadeum Life Sciences launched the Microbubble Leukopak Human T Cell Isolation Kit in September 2022, revolutionizing cell separation. This kit utilizes microbubble technology combined with Buoyancy Activated Cell Sorting (BACSTM) Separation Tubes, enhancing productivity by processing double the leukopaks in one-third of the usual time, thereby optimizing laboratory operations.
In July 2021, Eli Lilly and Company, a US-based multinational pharmaceutical company acquired Protomer Technologies for $1 billion. Through this acquisition, Eli Lilly and Company aims to strengthen its product portfolio in biomolecules and accelerate the development of these next-generation therapeutics. Protomer Technologies is a US-based manufacturing and engineering of peptide molecules, including non-therapeutics molecule.

Major companies operating in the non-therapeutic biomolecules market report are ABB Ltd., Schneider Electric SE, Eaton Corporation PLC, Larsen & Toubro Ltd., Siemens AG, LS Electric Co. Ltd., Entec Electric & Electronic Co. Ltd., EPE Switchgear (M) Sdn. Bhd, Lucy Electric Ltd., Ormazabal Corporación Empresarial S.L., Crompton Greaves Consumer Electricals Limited, Orecco Electric d.o.o, Alfanar Group Ltd., LSIS Co.Ltd., Toshiba Corp., CG Power & Industrial Solutions Ltd., SwitchGear Company NV, NOJA Power Switchgear Pty Ltd., G&W Electric Company, C&S Electric Limited, E+I Engineering Ltd., Hawker Siddeley Switchgear Ltd., Kappa Engineering (Pty) Ltd., KONČAR - Electrical Industry Inc., Laxmi Electronics Pvt. Ltd., MGC Moser-Glaser AG, Mors Smitt B.V, Nissin Electric Co. Ltd., RPS Switchgear Limited, S&S Power Switchgear Limited, Slaters Electricals Ltd., Switchgear Power Systems LLC, Tavrida Electric AG, TE Connectivity Ltd., TGOOD Global Ltd., Trayer Engineering Corporation, VEO Oy, Wahah Electric Supply Company of Saudi Arabia Co., Xiamen Huadian Switchgear Co. Ltd.

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2023. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the non-therapeutic biomolecules market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-therapeutic biomolecule market consists of sales of monosaccharides, disaccharides, polysaccharides, heteropolysaccharides, structural proteins, hormones, respiratory pigments, storage proteins, toxins, deoxyribonucleic acids (DNA), ribonucleic acids (RNA), fatty acids, phospholipids, steroids, eicosanoids, and glycolipids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Non-Therapeutic Biomolecules Market Characteristics3. Non-Therapeutic Biomolecules Market Trends and Strategies
4. Non-Therapeutic Biomolecules Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Non-Therapeutic Biomolecules Market Size and Growth
5.1. Global Non-Therapeutic Biomolecules Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Non-Therapeutic Biomolecules Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Non-Therapeutic Biomolecules Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Non-Therapeutic Biomolecules Market Segmentation
6.1. Global Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Enzymes
  • Recombinant Proteins
  • Plasmids
  • Peptides
  • Oligonucleotides
  • Monoclonal Antibodies
6.2. Global Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Research
  • Pharma
  • in vitro diagnostics(IVD)
7. Non-Therapeutic Biomolecules Market Regional and Country Analysis
7.1. Global Non-Therapeutic Biomolecules Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Non-Therapeutic Biomolecules Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Non-Therapeutic Biomolecules Market
8.1. Asia-Pacific Non-Therapeutic Biomolecules Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Non-Therapeutic Biomolecules Market
9.1. China Non-Therapeutic Biomolecules Market Overview
9.2. China Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Non-Therapeutic Biomolecules Market
10.1. India Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Non-Therapeutic Biomolecules Market
11.1. Japan Non-Therapeutic Biomolecules Market Overview
11.2. Japan Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Non-Therapeutic Biomolecules Market
12.1. Australia Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Non-Therapeutic Biomolecules Market
13.1. Indonesia Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Non-Therapeutic Biomolecules Market
14.1. South Korea Non-Therapeutic Biomolecules Market Overview
14.2. South Korea Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Non-Therapeutic Biomolecules Market
15.1. Western Europe Non-Therapeutic Biomolecules Market Overview
15.2. Western Europe Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Non-Therapeutic Biomolecules Market
16.1. UK Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Non-Therapeutic Biomolecules Market
17.1. Germany Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Non-Therapeutic Biomolecules Market
18.1. France Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Non-Therapeutic Biomolecules Market
19.1. Italy Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Non-Therapeutic Biomolecules Market
20.1. Spain Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Non-Therapeutic Biomolecules Market
21.1. Eastern Europe Non-Therapeutic Biomolecules Market Overview
21.2. Eastern Europe Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Non-Therapeutic Biomolecules Market
22.1. Russia Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Non-Therapeutic Biomolecules Market
23.1. North America Non-Therapeutic Biomolecules Market Overview
23.2. North America Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Non-Therapeutic Biomolecules Market
24.1. USA Non-Therapeutic Biomolecules Market Overview
24.2. USA Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Non-Therapeutic Biomolecules Market
25.1. Canada Non-Therapeutic Biomolecules Market Overview
25.2. Canada Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Non-Therapeutic Biomolecules Market
26.1. South America Non-Therapeutic Biomolecules Market Overview
26.2. South America Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Non-Therapeutic Biomolecules Market
27.1. Brazil Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Non-Therapeutic Biomolecules Market
28.1. Middle East Non-Therapeutic Biomolecules Market Overview
28.2. Middle East Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Non-Therapeutic Biomolecules Market
29.1. Africa Non-Therapeutic Biomolecules Market Overview
29.2. Africa Non-Therapeutic Biomolecules Market, Segmentation by Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Non-Therapeutic Biomolecules Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Non-Therapeutic Biomolecules Market Competitive Landscape and Company Profiles
30.1. Non-Therapeutic Biomolecules Market Competitive Landscape
30.2. Non-Therapeutic Biomolecules Market Company Profiles
30.2.1. ABB Ltd.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Schneider Electric SE
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Eaton Corporation plc
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Larsen & Toubro Ltd.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Siemens AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Non-Therapeutic Biomolecules Market Competitive Benchmarking32. Global Non-Therapeutic Biomolecules Market Competitive Dashboard33. Key Mergers and Acquisitions in the Non-Therapeutic Biomolecules Market
34. Non-Therapeutic Biomolecules Market Future Outlook and Potential Analysis
34.1 Non-Therapeutic Biomolecules Market in 2028 - Countries Offering Most New Opportunities
34.2 Non-Therapeutic Biomolecules Market in 2028 - Segments Offering Most New Opportunities
34.3 Non-Therapeutic Biomolecules Market in 2028 - Growth Strategies
34.3.1 Market Trend-based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic and Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Analyst
35.6. Copyright and Disclaimer

Executive Summary

This report provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-therapeutic biomolecules market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for non-therapeutic biomolecules? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Scope

Markets Covered:

1) By Trad Pharma: Enzymes; Recombinant Proteins; Plasmids; Peptides; Oligonucleotides; Monoclonal Antibodies
2) By End User: Research; Pharma; In vitro diagnostics(IVD)

Key Companies Mentioned: ABB Ltd.; Schneider Electric SE; Eaton Corporation PLC; Larsen & Toubro Ltd.; Siemens AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned

A selection of companies mentioned in this report includes:

  • ABB Ltd.
  • Schneider Electric SE
  • Eaton Corporation PLC
  • Larsen & Toubro Ltd.
  • Siemens AG
  • LS Electric Co. Ltd
  • Entec Electric & Electronic Co. Ltd
  • EPE Switchgear (M) Sdn. Bhd
  • Lucy Electric Ltd.
  • Ormazabal Corporación Empresarial S.L.
  • Crompton Greaves Consumer Electricals Limited
  • Orecco Electric d.o.o
  • Alfanar Group Ltd.
  • LSIS Co. Ltd.
  • Toshiba Corp.
  • CG Power & Industrial Solutions Ltd.
  • SwitchGear Company NV
  • NOJA Power Switchgear Pty Ltd.
  • G&W Electric Company
  • C&S Electric Limited
  • E+I Engineering Ltd.
  • Hawker Siddeley Switchgear Ltd.
  • Kappa Engineering (Pty) Ltd.
  • KONČAR - Electrical Industry Inc.
  • Laxmi Electronics Pvt. Ltd.
  • MGC Moser-Glaser AG
  • Mors Smitt B.V
  • Nissin Electric Co. Ltd.
  • RPS Switchgear Limited
  • S&S Power Switchgear Limited
  • Slaters Electricals Ltd.
  • Switchgear Power Systems LLC
  • Tavrida Electric AG
  • TE Connectivity Ltd.
  • TGOOD Global Ltd.
  • Trayer Engineering Corporation
  • VEO Oy
  • Wahah Electric Supply Company of Saudi Arabia Co.
  • Xiamen Huadian Switchgear Co. Ltd.

Methodology

Loading
LOADING...